
About Nihon Kohden
Nihon Kohden is a publicly listed company based in Tokyo (Japan) founded in 1951. Manufacturer, Exporter, importer and Supplier of Medical equipment. It operates in the Healthcare and Technology sectors. The company has 6,110 employees. Nihon Kohden has completed 6 acquisitions, including AMP3D, Ad-Tech Medical Instrument and Defibtech. Its website nihonkohden.com draws about 60 thousand monthly visits. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Monitoring Devices.
Company details
Nihon Kohden is a Japanese producer and exporter of medical equipment. Its major product lines for export are patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators, intraoperative neuromonitoring and hematology analyzers. Nihon Kohden also imports and supplies overseas products into Japan. Their range of imported equipment includes cardiology, urology, respiratory care, anesthesiology, emergency care, sports medicine and rehabilitation. In Japan, their extensive domestic sales network consists of over 650 direct sales staff with over 100 offices throughout the country.
- Headquarters Tokyo, Japan
- Employees 6,110
- Stage Public
- SectorsHealthcareTechnology
- Website nihonkohden.com/index.html
- Social LinkedIn X Facebook
- Legal Name Nihon Kohden Corporation
- Annual Revenue$1.47 B (USD)4.29as on Mar 31, 2026
- Net Profit$90.97 M (USD)2.95as on Mar 31, 2026
- EBITDA$154.23 M (USD)-1.2as on Mar 31, 2026
- Employee Count6,110
- Investments & AcquisitionsAMP3D
& 5 more
IPO & Listings of Nihon Kohden
Nihon Kohden is a publicly listed company on the TSE with ticker symbol 6849 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date02 Nov 1961
- Listed onTSE: 6849
- Listed entityNihon Kohden Corporation
- Exchange sectorHealth technology
- ISINJP3706800004
- Share price1,652.50 JPY (+0.24% on the day) · 2026-10-14
- Market capitalisation270,259,521,149.00 JPY
- Price to earnings19.7
- EPS (diluted, trailing year)83.69 JPY
- Dividend yield1.95%
- Volume (last session)788,100
Financials of Nihon Kohden
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 235.10B JPY | 14.51B JPY | 24.60B JPY |
| 2024 | 225.42B JPY | 14.10B JPY | 24.90B JPY |
| 2023 | 221.99B JPY | 17.03B JPY | 23.45B JPY |
| 2022 | 206.60B JPY | 17.11B JPY | 24.91B JPY |
| 2021 | 205.13B JPY | 23.43B JPY | 34.48B JPY |
Detailed financial statements for Nihon Kohden
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nihon Kohden
Nihon Kohden has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include AMP3D, Ad-Tech Medical Instrument and Defibtech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Neurosurgical instruments and electrodes are developed for epilepsy treatment. | adtechmedical.com | Racine, United States | 1983 | Dec 2024 | β’β’β’β’ | |
| neuroadvancedcorp.tcc.mode | 0 | Nov 2024 | β’β’β’β’ | |||
SaaS-based Big Data analytics platform for earlier intervention of potentially catastrophic events with sub-acute prodrome | amp3d.biz | Charlottesville, United States | 2014 | Aug 2021 | β’β’β’β’ | |
AEDs and resuscitation products are designed and manufactured. | defibtech.com | Guilford, United States | 1999 | Oct 2012 | β’β’β’β’ | |
Sleep diagnostic devices and software are developed for portable use. | neurotronics.com | Gainesville, United States | 1971 | Dec 2008 | β’β’β’β’ | |
Pathology lab services are delivered via a chain in Mexico. | labnova.com | Durango, Mexico | 2007 | May 2006 | β’β’β’β’ |
Complete acquisition details for Nihon Kohden
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nihon Kohden
8 dated milestones of Nihon Kohden across 73 years, from founding to its latest funding, stage changes and deals.
- Founded Nihon Kohden is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Laboratorio Nova.
- Acquisition Acquires Neurotronics.
- Acquisition Acquires Defibtech.
- Acquisition Acquires AMP3D.
- Acquisition Acquires Neuroadvancedcorp.
- Acquisition Acquires Ad-Tech Medical Instrument.
Web traffic of Nihon Kohden
The website of Nihon Kohden (nihonkohden.com) receives about 60.5K visits a month.
- Monthly visits60.5K
▼ 23% vs previous month
Websites whose visitors overlap most with Nihon Kohden. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nkusa.com | nkusa.com | 100% | β | ||
medical.philips.com | medical.philips.com | 96% | β | ||
maquet.ru | maquet.ru | 87% | β | ||
neurosoft.ru | neurosoft.ru | 87% | β | ||
| alcon.com | 87% | 171K | #286,128 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Nihon Kohden
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nihon Kohden
Complete news archive for Nihon Kohden
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nihon Kohden
Nihon Kohden was founded in 1951.
Nihon Kohden is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Nihon Kohden has 6,110 employees.
Annual revenue of Nihon Kohden is $1.47B as on Mar 31, 2026.
Nihon Kohden is a Japanese producer and exporter of medical equipment. Its major product lines for export are patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators, intraoperative neuromonitoring and hematology analyzers. Nihon Kohden also imports and supplies overseas products into Japan. Their range of imported equipment includes cardiology, urology, respiratory care, anesthesiology, emergency care, sports medicine and rehabilitation. In Japan, their extensive domestic sales network consists of over 650 direct sales staff with over 100 offices throughout the country.
Yes, Nihon Kohden is publicly traded on TSE under the ticker symbol 6849.
Nihon Kohden has made 6 acquisitions, including AMP3D, Ad-Tech Medical Instrument, and Defibtech.
